Christopher R. Cogle
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 1%
- Mesenchymal stem cell research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Virus-based gene therapy research
Papers in
- Hematology 94
- Acute Myeloid Leukemia Research 76
- Hematopoietic Stem Cell Transplantation 22
- Chronic Myeloid Leukemia Treatments 11
-
- Protein Degradation and Inhibitors 14
- Co-authors
- Edward W. Scott (23 shared papers)John R. Wingard (23 shared papers)Dana E. Rollison (5 shared papers)Alan F. List (5 shared papers)Benjamin M. Craig (3 shared papers)Dani S. Zander (3 shared papers)Guillermo Garcia‐Manero (15 shared papers)Grant McFadden (11 shared papers)
- Journals
- Blood (48 papers)Leukemia Research (15 papers)Journal of Clinical Oncology (5 papers)Experimental Hematology (4 papers)Cancers (4 papers)
- Partner nations
- United StatesUnited KingdomHungary
In The Last Decade
Christopher R. Cogle
154 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 125
- Hematology 1.5k
- Genetics 735
- Developmental Neuroscience 114
- Cancer Research 406
- Oncology 724
Countries citing papers authored by Christopher R. Cogle
This map shows the geographic impact of Christopher R. Cogle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Cogle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Cogle more than expected).
Fields of papers citing papers by Christopher R. Cogle
This network shows the impact of papers produced by Christopher R. Cogle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Cogle. The network helps show where Christopher R. Cogle may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher R. Cogle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 253 | |
| 2 | 2011 | 206 | |
| 3 | 2011 | 167 | |
| 4 | 2008 | 150 | |
| 5 | 2019 | 131 | |
| 6 | 2005 | 108 | |
| 7 | 2015 | 100 | |
| 8 | 2015 | 90 | |
| 9 | 2022 | 82 | |
| 10 | 2014 | 70 | |
| 11 | 2003 | 70 | |
| 12 | 2010 | 68 | |
| 13 | 2012 | 64 | |
| 14 | 2013 | 64 | |
| 15 | 2007 | 64 | |
| 16 | 2021 | 63 | |
| 17 | 2011 | 58 | |
| 18 | 2015 | 57 | |
| 19 | 2012 | 57 | |
| 20 | 2018 | 52 |
About Christopher R. Cogle
Christopher R. Cogle is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Immunology, having authored 165 papers that have together received 3.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (76 papers), Hematopoietic Stem Cell Transplantation (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Protein Degradation and Inhibitors (14 papers), Mesenchymal stem cell research (13 papers), Virus-based gene therapy research (12 papers), CAR-T cell therapy research (12 papers) and Chronic Myeloid Leukemia Treatments (11 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (735 citations), Developmental Neuroscience (114 citations), Cancer Research (406 citations) and Oncology (724 citations). Christopher R. Cogle has collaborated with scholars based in United States, United Kingdom and Hungary. Frequent co-authors include Edward W. Scott, John R. Wingard, Dana E. Rollison, Alan F. List, Benjamin M. Craig, Dani S. Zander, Guillermo Garcia‐Manero, Grant McFadden, Jan S. Moreb and Eric D. Laywell. Their work appears in journals such as Blood, Leukemia Research, Journal of Clinical Oncology, Experimental Hematology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.